Drug development

#Clinical trials #Covid-19 #Drug delivery #Drug development #Immunology / Virology & Vaccines #Johnson & Johnson #Vaccines

Janssen single-dose COVID-19 vaccine approved for use in the UK

Johnson & Johnson has announced topline efficacy and safety data from the Phase III ENSEMBLE clinical trial, demonstrating that the investigational single-dose Covid-19 vaccine in development at Janssen Pharmaceutical Companies met all primary and key secondary endpoints. The topline safety and efficacy data are based on 43,783 participants accruing 468… Read More

#Covid-19 #News #Trending News

#Clinical trial #Covid-19 #Drug development

Covid-19 patients with sepsis one step closer to life-saving treatment

A clinical trial has begun using a human protein called Annexin A5, which is being studied as a potential therapy for Covid-19 patients with sepsis. Annexin A5 is a protein produced inside the human body with unique anti-coagulation (preventing blood clots) and anti-inflammatory properties that could help in the fight… Read More

#News

#Cancer research #Drug development #Drug repositioning #Research

Can common drugs boost immunotherapy cancer treatments?

Widely-used anti-inflammatory drugs make tumours more responsive to treatments which boost the anti-cancer function of the immune system, according to early research by the University of Manchester, funded by Cancer Research UK. The proof-of-concept study on the combination of immunotherapy with anti-inflammatory drugs – used to manage pain and reduce… Read More

#Cancer Research #Editor's Choice #News

#Covid-19 #Drug delivery #Drug development

EMA issues positive scientific opinion on early treatment of Covid-19

GlaxoSmithKline (GSK) and Vir Biotechnology have announced that the European Medicines Agency’s (EMA) Committee for Human Medicinal Products (CHMP) has issued a positive scientific opinion following the referral of sotrovimab to the CHMP under Article 5(3) of Regulation 726/2004. This relates to the use of sotrovimab for the treatment of… Read More

#Covid-19 #News

#Biotherapeutics #Drug development #Nanomedicine / nanotechnology #Research

New platform uses nanothechnolgy to deliver therapeutics

The Infection Innovation Consortium (iiCON) has launched The Nanotherapeutics Hub, based at the University of Liverpool in the UK, part of Liverpool’s Centre of Excellence for Long-acting Therapeutics (CELT). The agreement will see The Nanotherapeutics Hub work with iiCON to support companies looking to develop nanotherapeutics to combat infectious diseases… Read More

#Editor's Choice #News

Doctor administering a vaccine to patient
#Drug delivery #Drug development #Gene therapy #In vivo

Collaboration expands reach in next generation vaccines

Gamma Biosciences has agreed to make a controlling investment in Mirus Bio for nucleic acid delivery based in Madison, Wisconsin. The transaction will support Mirus’ plans to expand good manufacturing practice (GMP) production and commercialisation of its flagship product TransIT VirusGEN for large scale manufacturing of AAV and LV-based viral… Read More

#News

#Drug development #Drug discovery #Malaria #Research

Malaria stopped in its tracks with new drug compound

Researchers at the Francis Crick Institute and the Latvian Institute of Organic Synthesis have designed a drug-like compound which effectively blocks a critical step in the malaria parasite life cycle and are working to develop this compound into a potential first of its kind malaria treatment. While drugs and mosquito… Read More

#News

#AI #Biobanking #Drug development #Drug discovery #Machine learning #Narrated podcasts

Precision medicine in the era of artificial intelligence

This is the latest episode of the free DDW podcast, “Precision medicine in the era of artificial intelligence”. It covers one narrated article of the same title written for DDW and read aloud by Megan Thomas. It was written by Dr Lofti Chouchane and Dr Javaid Sheikh, who discuss the value… Read More

#Podcasts

#Drug development #Drug discovery #ELRIG #Events #Life sciences

Weather the Storm: Drug Discovery and the ELRIG community

On May 27, 2021, ELRIG’s “hot topic” webinar, Weathering the Storm: Drug Discovery & the ELRIG Community takes place virtually. Scientists, medical professionals, business leaders and others associated with the life sciences, which ELRIG consider to be the core of their drug discovery community, and who, throughout the pandemic, have… Read More

#News

#Biopharmaceuticals #Biotechnology #Drug development #Novel therapeutics

PerkinElmer acquires Nexcelom Bioscience

PerkinElmer has entered into an agreement to acquire Nexcelom Bioscience for US$260 million. The transaction is expected to close during the second quarter of 2021. Nexcelom provides automated cell counting instruments and aids in the development of cell and gene and immuno-oncology therapies, virology drugs and vaccines. Its expected 2021… Read More

#News

#Alzheimer's #Clinical trial #Drug development #Drug discovery #Drug targets #Immuno-oncology

Can this clinical trial move us closer to an Alzheimer’s treatment?

Exscientia has announced a Phase I clinical study of DSP-0038 in the US for the treatment of Alzheimer’s disease psychosis. DSP-0038 is the third molecule created using Exscientia’s Artificial Intelligence (AI) technologies to enter clinical trials. The two earlier compounds are DSP-1181, announced in 2020 together with Sumitomo Dainippon Pharma… Read More

#News

#Antibodies #Awards #Biologics / Biotechnology #Drug development #Oncology #Therapeutics

Matwin spotlights innovation in the fight against cancer

Matwin has picked four companies that will now receive investment from the French oncology accelerator. This was during the MEET2WIN European Oncology Partnering Convention. Step Pharma was awarded ‘First-in-class therapeutic innovation’. The startup’s lead program (STP938) is based on a novel class of oral nucleotide synthesis inhibitors that target CTPS1… Read More

#News

#Clinical trials #Database #Drug development #Research

Clinical trials database will save researchers time and resources

The National Institute for Health Research’s Innovation Observatory (NIHRIO), based at Newcastle University, has launched a comprehensive database of clinical trials as well as FDA-approved medical devices, diagnostics and digital applications. Designed as a free resource, researchers can access information about what research is in progress in their area… Read More

#News

#Cell / tissue culture #Drug development #Synthetic biology

Synthetic cells could help study drug activity in living tissues

Scientists have created new artificial tissues that mimic some of the complex characteristics and abilities of living tissues, paving the way towards unprecedented advances in medicine, soft-robotics, and micro-engineering. The University of Bristol-led breakthrough, published in Advanced Materials, has reported the first way to produce centimetre-sized artificial tissues of any… Read More

#News